Home > Financial Ratios > LINCOLN PHARMACEUTICALS

LINCOLN PHARMACEUTICALS
EBIT Growth

    Back to All Ratios
LINCOLN PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

LINCOLN PHARMACEUTICALS Last 5 Year EBIT Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EBIT Growth(%) -10.2120.685.2614.2023.15

What is the latest EBIT Growth ratio of LINCOLN PHARMACEUTICALS ?

The latest EBIT Growth ratio of LINCOLN PHARMACEUTICALS is -10.21 based on Mar2025 Consolidated results.
Year EBIT Growth
Mar2025-10.21
Mar202420.68
Mar20235.26
Mar202214.20
Mar202123.15

How is EBIT Growth of LINCOLN PHARMACEUTICALS Trending?

Years EBIT Growth % Change
Mar2025 -10.21
Negative
Mar2024 20.68
293.16
Mar2023 5.26
-62.96
Mar2022 14.2
-38.66
Mar2021 23.15 -

Other Financial Ratios of LINCOLN PHARMACEUTICALS


Compare EBIT Growth ratio of peers of LINCOLN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS ₹1,168.0 Cr -7.5% -4.8% 10.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹427,693.0 Cr -1.7% 4% 11.8% Stock Analytics
DIVIS LABORATORIES ₹161,270.0 Cr -4.7% -1.8% 10.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹144,281.0 Cr -3.7% 4.5% 42.9% Stock Analytics
DR REDDYS LABORATORIES ₹106,422.0 Cr -3% 0% 15.4% Stock Analytics
CIPLA ₹104,915.0 Cr -2.6% -2.3% -10.1% Stock Analytics


LINCOLN PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS

-7.5%

-4.8%

10.9%

SENSEX

-2.7%

-10.4%

1.6%


You may also like the below Video Courses